Eli Lilly became the world's first trillion-dollar pharmaceutical company by market capitalization in 2026
Tirzepatide Side Effects# Well-characterized from Phase 3 (SURPASS, SURMOUNT) trials and post-market surveillance: Gastrointestinal : Nausea (12-33%), diarrhea (12-21%), vomiting (5-12%), constipation (6-11%) Decreased appetite : Common and expected pharmacological effect Injection site reactions : Mild, occurring in 2-5% of patients Pancreatitis : Rare
Where GLP-1s Fit in the Menopausal Framework Returning to the framework established in the previous section, the menopausal transition represents a disruption operating on two levels: the upstream withdrawal of hormonal signaling, and the downstream metabolic consequences that withdrawal produces
At Vivion, were staying on top of GLP-1 agonist users particular nutritional supplement needs
At higher doses like 12.5 mg or 15 mg per week , you burn through medication faster and may need to reorder more frequently
Wilson L, Stewart W, Dams-OConnor K, Diaz-Arrastia R, Horton L, Menon DK, Polinder S (2017) The chronic and evolving neurological consequences of traumatic brain injury